Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Colorectal Neoplasms

Free Subscription Articles published in Am J Clin Oncol Retrieve available abstracts of 19 articles: HTML format Text format

Single Articles

June 2019
1. KOENIG JL, Toesca DAS, Harris JP, Tsai CJ, et al
   Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer.
   Am J Clin Oncol. 2019 Jun 3. doi: 10.1097/COC.0000000000000554.
   PubMed     Text format     Abstract available
   
   
   April 2019
2. ALI ND, Donohue K, Zandieh S, Chen C, et al
   Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living >/=24 Months: A Single Institutional Study.
   Am J Clin Oncol. 2019 Apr 9. doi: 10.1097/COC.0000000000000535.
   PubMed     Text format     Abstract available
   
   
   March 2019
3. LLOYD S, Baraghoshi D, Tao R, Garrido-Laguna I, et al
   Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival.
   Am J Clin Oncol. 2019 Mar 5. doi: 10.1097/COC.0000000000000529.
   PubMed     Text format     Abstract available
   
   
   February 2019
4. AHMED S, Baig T, Iqbal N, Le D, et al
   Effects of Social and Contextual Factors Including Marital Status and Children on the Use of Palliative Chemotherapy in Metastatic Colorectal Cancer.
   Am J Clin Oncol. 2019 Feb 15. doi: 10.1097/COC.0000000000000530.
   PubMed     Text format     Abstract available
   
   
   July 2018
5. CUBILLO A, Alvarez-Gallego R, Munoz M, Pond G, et al
   Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer.
   Am J Clin Oncol. 2018 Jul 2. doi: 10.1097/COC.0000000000000474.
   PubMed     Text format     Abstract available
   
   
   May 2018
6. CHEN EY, Blanke CD, Haller DG, Benson AB, et al
   A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer.
   Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000465.
   PubMed     Text format     Abstract available
   
   
   April 2018
7. BATES JE, Choi G, Usuki KY, Katz AW, et al
   Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy.
   Am J Clin Oncol. 2018 Apr 16. doi: 10.1097/COC.0000000000000445.
   PubMed     Text format     Abstract available
   
   
   March 2018
8. MCCLURE LA, Sussman DA, Hernandez MN, Tannenbaum SL, et al
   Factors Associated With Receipt of Radiation Therapy for Rectal Cancer.
   Am J Clin Oncol. 2018;41:227-229.
   PubMed     Text format     Abstract available
   
   
   February 2018
9. NGUYEN P, Wuthrick E, Chablani P, Robinson A, et al
   Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.
   Am J Clin Oncol. 2018;41:140-146.
   PubMed     Text format     Abstract available
   
   
   
10. DESHMUKH AA, Zhao H, Franzini L, Lairson DR, et al
    Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United States.
    Am J Clin Oncol. 2018;41:121-127.
    PubMed     Text format     Abstract available
    
    
    January 2018
11. LAURENT M, Des Guetz G, Bastuji-Garin S, Culine S, et al
    Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6.
    Am J Clin Oncol. 2018;41:73-80.
    PubMed     Text format     Abstract available
    
    
    
12. SHANKARAN V, Ortendahl JD, Purdum AG, Bolinder B, et al
    Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States.
    Am J Clin Oncol. 2018;41:65-72.
    PubMed     Text format     Abstract available
    
    
    
13. QIU H, Katz AW, Chowdhry AK, Usuki KY, et al
    Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.
    Am J Clin Oncol. 2018;41:53-58.
    PubMed     Text format     Abstract available
    
    
    December 2017
14. CHABLANI P, Nguyen P, Pan X, Robinson A, et al
    Perineural Invasion Predicts for Distant Metastasis in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation and Surgery.
    Am J Clin Oncol. 2017;40:561-568.
    PubMed     Text format     Abstract available
    
    
    
15. VOONG KR, Rashid A, Crane CH, Minsky BD, et al
    Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
    Am J Clin Oncol. 2017;40:555-560.
    PubMed     Text format     Abstract available
    
    
    
16. OSTI MF, Nicosia L, Agolli L, Gentile G, et al
    Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy.
    Am J Clin Oncol. 2017;40:535-542.
    PubMed     Text format     Abstract available
    
    
    
17. AHN DH, Wu C, Wei L, Williams TM, et al
    The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.
    Am J Clin Oncol. 2017;40:531-534.
    PubMed     Text format     Abstract available
    
    
    October 2017
18. YEOP OH S, Bae Kim Y, Wook Suh K
    Oncologic Outcome of ypT1-2N0 Rectal Cancer After Neoadjuvant Chemoradiotherapy Compared With pT1-2N0 Rectal Cancer.
    Am J Clin Oncol. 2017;40:512-516.
    PubMed     Text format     Abstract available
    
    
    
19. CHARLTON ME, Karlitz JJ, Schlichting JA, Chen VW, et al
    Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study.
    Am J Clin Oncol. 2017;40:498-506.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: